Related Experiment Video
Updated: May 21, 2026
Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
Association between iron status and inflammation markers with GDF15 and BMP6 in inflammatory bowel disease: a single
Yusuf Üstün1,2, Sinan Yanık3,4, Fatma Uçar3,5
1University of Health Sciences, Dışkapı Yıldırım Beyazıt Education and Research Hospital, Gastroenterology Clinic, Ankara, Turkey. yusufus@hotmail.com.
Background:
Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are chronic disorders with relapsing and remitting disease courses. Several clinical indicators and biomarkers have been evaluated for their clinical utility in assessing disease prognosis and monitoring disease activity. This study evaluated the utility of growth differentiation factor-15 (GDF15) and bone morphogenetic protein-6 (BMP6) in inflammatory pathways and iron regulation in IBD.
Methods:
Between September 2015 and March 2016, this single-center, cross-sectional study included 40 CD patients, 29 UC patients, and 70 healthy controls. The disease activity was measured using the Mayo score and the Crohn's Disease Activity Index (CDAI). Serum iron, hematological indices, inflammatory markers, and the novel biomarkers BMP6 and GDF15 as determined by ELISA were evaluated.
Results:
Both the CD and UC groups showed significantly lower serum iron (p < 0.001), reduced mean corpuscular hemoglobin concentration, and higher red cell distribution width than the control group. Inflammatory markers, including erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), were elevated in IBD, particularly during active disease, with CRP increasing significantly in active UC compared to remission (p = 0.040). In contrast, BMP6 and GDF15 levels did not differ significantly between the disease groups or activity states. Nonetheless, GDF15 demonstrated moderate positive correlations with serum iron (r = 0.314), hemoglobin (r = 0.320), and mean corpuscular hemoglobin concentration (MCHC) (r = 0.344), suggesting a link to erythropoietic or iron-related processes rather than inflammation.
Conclusions:
Conventional markers reliably confirmed iron deficiency and inflammation in IBD. BMP6 and GDF15 levels did not differ significantly across disease states, indicating limited utility as markers of disease activity. Notably, GDF15 was positively correlated with serum iron, hemoglobin, and MCHC, suggesting its association with iron metabolism rather than active inflammation. Larger longitudinal studies are warranted to validate this potential role.
Trial Registration:
Not applicable.
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:25Inflammatory Bowel Disease III: Crohn's Disease
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis